Deng ZK - Search Results

1

Three-Level Hepatotoxicity Prediction System Based on Adverse Hepatic Effects.

Liu L, Fu L, Zhang JW, Wei H, Ye WL, Deng ZK, Zhang L, Cheng Y, Ouyang D, Cao Q, Cao DS. Liu L, et al. Among authors: deng zk. Mol Pharm. 2019 Jan 7;16(1):393-408. doi: 10.1021/acs.molpharmaceut.8b01048. Epub 2018 Dec 14. Mol Pharm. 2019. PMID: 30475633

2

Identification of a Novel Bcl-2 Inhibitor by Ligand-Based Screening and Investigation of Its Anti-cancer Effect on Human Breast Cancer Cells.

Wen M, Deng ZK, Jiang SL, Guan YD, Wu HZ, Wang XL, Xiao SS, Zhang Y, Yang JM, Cao DS, Cheng Y. Wen M, et al. Among authors: deng zk. Front Pharmacol. 2019 Apr 17;10:391. doi: 10.3389/fphar.2019.00391. eCollection 2019. Front Pharmacol. 2019. PMID: 31057406 Free PMC article.

3

The first attempt for closure of the patent foramen ovale under guidance of teleoperation ultrasonic robot: a case report.

Wei Y, Zhou H, Zhao MX, Wang C, Wang SY, Deng ZK, Zhu H. Wei Y, et al. Among authors: deng zk. J Geriatr Cardiol. 2023 Feb 28;20(2):159-162. doi: 10.26599/1671-5411.2023.02.008. J Geriatr Cardiol. 2023. PMID: 36910246 Free PMC article. No abstract available.

4

[Transcriptome Analysis of Chronic Myelogenous Leukemia Cell Line with Imatinib Resistance].

Han X, Deng ZK, Zhang CW, Yu L, Liu XN. Han X, et al. Among authors: deng zk. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Dec;29(6):1714-1718. doi: 10.19746/j.cnki.issn.1009-2137.2021.06.004. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34893099 Chinese.

5

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer.

Liang YK, Deng ZK, Chen MT, Qiu SQ, Xiao YS, Qi YZ, Xie Q, Wang ZH, Jia SC, Zeng D, Lin HY. Liang YK, et al. Among authors: deng zk. Front Oncol. 2021 Aug 30;11:710286. doi: 10.3389/fonc.2021.710286. eCollection 2021. Front Oncol. 2021. PMID: 34527583 Free PMC article.

6

[Mechanism of mTOR Pathway in K562 cell Apoptosis Induced by Homoharringtonine].

Ding YH, Wu JJ, Wang Q, Deng ZK, Li YF. Ding YH, et al. Among authors: deng zk. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Feb;26(1):105-109. doi: 10.7534/j.issn.1009-2137.2018.01.017. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 29397826 Chinese.

7

Neuroprotective action and mechanistic evaluation of protodioscin against rat model of Parkinson's disease.

Wu J, Zhao YM, Deng ZK. Wu J, et al. Among authors: deng zk. Pharmacol Rep. 2018 Feb;70(1):139-145. doi: 10.1016/j.pharep.2017.08.013. Epub 2017 Aug 30. Pharmacol Rep. 2018. PMID: 29367101

8

Tangeretin ameliorates renal failure via regulating oxidative stress, NF-κB-TNF-α/iNOS signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats.

Wu J, Zhao YM, Deng ZK. Wu J, et al. Among authors: deng zk. Inflammopharmacology. 2018 Feb;26(1):119-132. doi: 10.1007/s10787-017-0394-4. Epub 2017 Sep 4. Inflammopharmacology. 2018. PMID: 28871498

9

[Effect of Homoharringtonine Combined with Imatinib on the K562/G01 Cells and Its Mechanism].

Wu JJ, Ding YH, Deng ZK, Shi YY, Lu XY, Li YF. Wu JJ, et al. Among authors: deng zk. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):80-84. doi: 10.7534/j.issn.1009-2137.2017.01.013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28245379 Chinese.

10

[Effects of PCI-32765 and Dasatinib on the Acute Lymphoblastic Leukemic Cells and Their Mechanisms].

Deng Y, Tao SD, Zhang X, Ma JJ, He ZM, Chen Y, Deng ZK, Yu L. Deng Y, et al. Among authors: deng zk. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):72-79. doi: 10.7534/j.issn.1009-2137.2017.01.012. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28245378 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters